Descriptor English: | Zanamivir | ||||
Descriptor Spanish: |
Zanamivir
| ||||
Descriptor Portuguese: | Zanamivir | ||||
Descriptor French: | Zanamivir | ||||
Entry term(s): |
2,3-Didehydro-2,4-Dideoxy-4-Guanidino-N-Acetyl-D-Neuraminic Acid 2,3-Didehydro-2,4-Dideoxy-4-Guanidinyl-N-Acetylneuraminic Acid 4 Guanidino 2 Deoxy 2,3 Didehydro N Acetylneuraminic Acid 4 Guanidino Neu5Ac2en 4-Guanidino-2,4-Dideoxy-2,3-Didehydro-N-Acetylneuraminic Acid 4-Guanidino-2-Deoxy-2,3-Didehydro-N-Acetylneuraminic Acid 4-Guanidino-Neu5Ac2en 5-Acetylamino-2,6-Anhydro-4-Guanidino-3,4,5-Trideoxy-D-Galacto-Non-Enoic Acid Acid, 4-Guanidino-2-Deoxy-2,3-Didehydro-N-Acetylneuraminic GG 167 GG-167 GG167 Relenza |
||||
Tree number(s): |
D02.078.370.926 D02.241.081.844.562.668.775 D02.241.511.902.562.668.775 D03.383.663.859 D09.067.687.668.775 D09.811.589.668.775 |
||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D053243 | ||||
Scope note: | A guanido-neuraminic acid that is used to inhibit NEURAMINIDASE. |
||||
Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||
Pharm Action: |
Antiviral Agents Enzyme Inhibitors |
||||
Registry Number: | L6O3XI777I | ||||
CAS Type 1 Name: | 5-acetylamino-4-guanidino-6-(1,2,3-trihydroxypropyl)-5,6-dihydro-4H-pyran-2-carboxylic acid | ||||
Public MeSH Note: | 2007; ZANAMIVIR was indexed under SIALIC ACIDS (1998-2006) |
||||
History Note: | 2007 |
||||
DeCS ID: | 52164 | ||||
Unique ID: | D053243 | ||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||
Date Established: | 2007/01/01 | ||||
Date of Entry: | 2006/07/05 | ||||
Revision Date: | 2017/05/24 |
-
-
CHEMICALS AND DRUGS
Organic Chemicals [D02]Organic Chemicals -
CHEMICALS AND DRUGS
Organic Chemicals [D02]Organic Chemicals -
CHEMICALS AND DRUGS
Organic Chemicals [D02]Organic Chemicals -
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds -
CHEMICALS AND DRUGS
Carbohydrates [D09]Carbohydrates -
CHEMICALS AND DRUGS
Carbohydrates [D09]Carbohydrates
|
Zanamivir
- Preferred
Relenza
- Narrower
GG 167
- Narrower
Concept UI |
M0217195 |
Scope note | A guanido-neuraminic acid that is used to inhibit NEURAMINIDASE. |
Preferred term | Zanamivir |
Entry term(s) |
2,3-Didehydro-2,4-Dideoxy-4-Guanidino-N-Acetyl-D-Neuraminic Acid 2,3-Didehydro-2,4-Dideoxy-4-Guanidinyl-N-Acetylneuraminic Acid 4 Guanidino 2 Deoxy 2,3 Didehydro N Acetylneuraminic Acid 4 Guanidino Neu5Ac2en 4-Guanidino-2,4-Dideoxy-2,3-Didehydro-N-Acetylneuraminic Acid 4-Guanidino-2-Deoxy-2,3-Didehydro-N-Acetylneuraminic Acid 4-Guanidino-Neu5Ac2en 5-Acetylamino-2,6-Anhydro-4-Guanidino-3,4,5-Trideoxy-D-Galacto-Non-Enoic Acid Acid, 4-Guanidino-2-Deoxy-2,3-Didehydro-N-Acetylneuraminic |
Concept UI |
M0338009 |
Preferred term | Relenza |
Concept UI |
M0217192 |
Preferred term | GG 167 |
Entry term(s) |
GG-167 GG167 |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey